LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Spine/Fracture Liaison Service Study Launched
Spine

Fracture Liaison Service Study Launched

December 16, 2013 2 min read Premium comments

Advertisement

Fracture Liaison Service Study Launched
Osteoprosis of the spine / Source: Wikimedia Commons and OpenStax College
Secondary

Osteoporosis groups are banding together to learn more about why the Fracture Liaison Service (FLS) model of post-fracture care has not been more widely implemented in the U.S. Led by the National Bone Health Alliance (NBHA), National Osteoporosis Foundation (NOF) and CECity.com, Inc. (CECity), the Bone Health Collaborative has announced the launch of a cloud-based Fracture Liaison Service Demonstration Study (FLS Demonstration) that will provide participating hospitals with the FLS model of care and CECity’s cloud-based MedConcert platform, to assess the hospitals’ adoption and implementation of a fracture liaison service across their communities. The FLS Demonstration Study, funded by Merck, is designed to demonstrate the ability to scale the FLS in the community setting, while measuring the impact on patient care.

The FLS Demonstration Study will leverage the experience and resources of each partner including NBHA’s fracture prevention knowledge and expertise; NOF’s expertise as the leading osteoporosis and bone health organization representing patients and healthcare professionals; and CECity’s MedConcert performance improvement platform, to engage providers in breaking down walls in order to build innovative communities of practice designed to improve the safety and quality of patient care.

The study will begin in early 2014 and run for approximately 12 months within the three initial sites selected for the study. The partners expect to publish results of the study by mid-2015.

“This Demonstration Project will advance the science of chronic disease management, ” said Dr. Sachin Jain, Merck’s chief medical information and innovation officer, in the December 5, 2013 news release. “By helping us scale Fracture Liaison Services and other chronic care programs, we will help delivery systems achieve better clinical results for their patients.”

Amy Porter, executive director and CEO of NOF, told OTW, “The Fracture Liaison Service Demonstration Study (FLS Demonstration) will track a number of quality and performance measures to evaluate the success of the study. We’ll know it’s successful a year from now if the data demonstrate improvement against these measures and that the program shows it is scalable in the community setting and has contributed to improvement in patient care, including patient diagnosis and treatment for osteoporosis.”

“The FLS Demonstration will help coordinate patient care across hospitals, medical offices and multiple medical specialties in the community to make it easier for doctors to communicate and ultimately improve safety and quality of care.”

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy